This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
Chromatin is a DNA and protein complex that creates chromosomes in eukaryotic cells' nuclei. Nuclear DNA is not found in loose strands; instead, it is heavily compressed and wrapped around nuclear proteins to fit inside the nucleus. There are two types of chromatin. Euchromatin is a less compacted type of chromatin that can be transcribed. The second type, known as heterochromatin, is severely compressed and rarely transcribed.
Heritable modifications in gene expression that do not entail changes to the underlying DNA sequence are referred to as epigenetics. Modifications in gene activity and expression are the most common epigenetic changes, although the phrase can also refer to any heritable phenotypic change. External or environmental influences may have an effect on cellular and physiological phenotypic features, or they may be a normal aspect of development. The phrase also refers to the changes themselves, which are functionally meaningful changes to the genome that do not involve a nucleotide sequence change.
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India